Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina
Introduction. Hepatitis E is a disease of global distribution, with significant morbidity and mortality, whose scope and burden continue to emerge in low endemic countries.Material and methods. In 2012, we studied the prevalence of anti-HEV antibodies in 202 adult serum samples. We also analyzed sam...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-09-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119312487 |
id |
doaj-c875f88cf04548219356fe53bcd883fa |
---|---|
record_format |
Article |
spelling |
doaj-c875f88cf04548219356fe53bcd883fa2021-06-09T05:53:49ZengElsevierAnnals of Hepatology1665-26812014-09-01135496502Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in ArgentinaMaría S. Munné, Ph.D.0Nancy R. Altabert1Lucio O. Otegui M.2Sara N. Vladimirsky3Rita Moreiro4María P. Espul5Carlos Espul6Abelardo Manzur7Sonia S. Soto8Leonardo S. Brajterman9Jorge E. González10National Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. Argentina; Correspondence and reprint request:National Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. ArgentinaNational Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. ArgentinaNational Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. ArgentinaLaboratory. Pediatric Hospital J.P. Garrahan. Ciudad Autónoma de Buenos Aires. ArgentinaVeterinary Science Faculty. Juan Mazza University. Mendoza. ArgentinaVirology Division. Central Hospital. Mendoza. ArgentinaVirology Division. Central Hospital. Mendoza. ArgentinaNational Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. ArgentinaNational Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. ArgentinaNational Reference Laboratory of Viral Hepatitis. National Institute of Infectious Diseases “Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires. ArgentinaIntroduction. Hepatitis E is a disease of global distribution, with significant morbidity and mortality, whose scope and burden continue to emerge in low endemic countries.Material and methods. In 2012, we studied the prevalence of anti-HEV antibodies in 202 adult serum samples. We also analyzed samples from 143 patients with acute non-A-C hepatitis from January 2011 to December 2013. Acute HEV infections were diagnosed with anti-HEV IgM and/or HEV RNA. HEV RNA was also investigated in 94 swine fecal samples. HEV RNA was sequenced and characterized.Results. We found higher values of prevalence than those previously reported in the 1990s. The overall prevalence of anti-HEV IgG antibodies was 15.4%. The prevalence was 10.6% in the 123 adults voluntarily screened on World Hepatitis Day 2012 in Buenos Aires city and 14.8, 16.7 and 35.7% respectively in the smaller groups of healthcare workers, blood donors and HIV-positive patients from different regions of the country. Nine acute HEV infections were diagnosed in the three years analyzed. We characterized new human variants of subgenotype 3a and 3i. New subgenotype 3i variants were found in swine from two distant provinces closely related to the human ones.Conclusions. These results enlarge the knowledge of HEV and contribute with new information. However, higher values of prevalence found in small groups need to be confirmed in larger studies. Many aspects of the spectrum of the disease and the reservoirs and routes of transmission are still unknown and thus deserve additional research.http://www.sciencedirect.com/science/article/pii/S1665268119312487DiagnosisMolecular epidemiologyGenotypeHEV RNAAcute infection |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
María S. Munné, Ph.D. Nancy R. Altabert Lucio O. Otegui M. Sara N. Vladimirsky Rita Moreiro María P. Espul Carlos Espul Abelardo Manzur Sonia S. Soto Leonardo S. Brajterman Jorge E. González |
spellingShingle |
María S. Munné, Ph.D. Nancy R. Altabert Lucio O. Otegui M. Sara N. Vladimirsky Rita Moreiro María P. Espul Carlos Espul Abelardo Manzur Sonia S. Soto Leonardo S. Brajterman Jorge E. González Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina Annals of Hepatology Diagnosis Molecular epidemiology Genotype HEV RNA Acute infection |
author_facet |
María S. Munné, Ph.D. Nancy R. Altabert Lucio O. Otegui M. Sara N. Vladimirsky Rita Moreiro María P. Espul Carlos Espul Abelardo Manzur Sonia S. Soto Leonardo S. Brajterman Jorge E. González |
author_sort |
María S. Munné, Ph.D. |
title |
Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina |
title_short |
Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina |
title_full |
Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina |
title_fullStr |
Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina |
title_full_unstemmed |
Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina |
title_sort |
updating the knowledge of hepatitis e: new variants and higher prevalence of anti-hev in argentina |
publisher |
Elsevier |
series |
Annals of Hepatology |
issn |
1665-2681 |
publishDate |
2014-09-01 |
description |
Introduction. Hepatitis E is a disease of global distribution, with significant morbidity and mortality, whose scope and burden continue to emerge in low endemic countries.Material and methods. In 2012, we studied the prevalence of anti-HEV antibodies in 202 adult serum samples. We also analyzed samples from 143 patients with acute non-A-C hepatitis from January 2011 to December 2013. Acute HEV infections were diagnosed with anti-HEV IgM and/or HEV RNA. HEV RNA was also investigated in 94 swine fecal samples. HEV RNA was sequenced and characterized.Results. We found higher values of prevalence than those previously reported in the 1990s. The overall prevalence of anti-HEV IgG antibodies was 15.4%. The prevalence was 10.6% in the 123 adults voluntarily screened on World Hepatitis Day 2012 in Buenos Aires city and 14.8, 16.7 and 35.7% respectively in the smaller groups of healthcare workers, blood donors and HIV-positive patients from different regions of the country. Nine acute HEV infections were diagnosed in the three years analyzed. We characterized new human variants of subgenotype 3a and 3i. New subgenotype 3i variants were found in swine from two distant provinces closely related to the human ones.Conclusions. These results enlarge the knowledge of HEV and contribute with new information. However, higher values of prevalence found in small groups need to be confirmed in larger studies. Many aspects of the spectrum of the disease and the reservoirs and routes of transmission are still unknown and thus deserve additional research. |
topic |
Diagnosis Molecular epidemiology Genotype HEV RNA Acute infection |
url |
http://www.sciencedirect.com/science/article/pii/S1665268119312487 |
work_keys_str_mv |
AT mariasmunnephd updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina AT nancyraltabert updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina AT lucioooteguim updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina AT saranvladimirsky updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina AT ritamoreiro updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina AT mariapespul updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina AT carlosespul updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina AT abelardomanzur updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina AT soniassoto updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina AT leonardosbrajterman updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina AT jorgeegonzalez updatingtheknowledgeofhepatitisenewvariantsandhigherprevalenceofantihevinargentina |
_version_ |
1721388869483495424 |